Pharmaceutical manufacturers of Propofol

Emcure Pharmaceuticals is driven by the purpose to develop, manufacture and market a broad range of pharmaceutical products globally. Our core strength and competitive advantage lie in our established presence in all major therapeutic areas including Gynaecology, cardiology, blood-related, oncology, respiratory, CNS & HIV among others. Emcure has launched 6 Biologics in the Domestic Market & RoW markets & they are the domestic leader in three biologics. With 350+ brands, five R&D centers and 13 manufacturing facilities established across the country, we have ensured a strong presence not just in India but also outside India with a wide network across 70+ countries. Our API facilities ensures that our supply chain is vertically integrated providing flexibility over control of manufacturing. We have cemented strategic global partnerships that are a result of alliances with local and multi-national companies which are at the helm of leadership in key therapeutic areas. The key objective of our widespread presence across markets is to constantly innovate and deliver affordable & high-quality healthcare solutions to people.

Established in 1984, Neuland Laboratories Limited is a publicly traded company based in Hyderabad, India. The organization offers solutions throughout the entire range of the pharmaceutical industry's chemical needs, from synthesizing library compounds to providing NCEs and advanced intermediates at different stages in the clinical life cycle, as well as for commercial launch. Neuland's specialty lies in the production of APIs and advanced intermediates from its facilities approved by the USFDA. Its primary expertise is the application of effective process chemistry to manufacturing in a compliant regulatory setting.

Harman Finochem Limited is an India-based Pharmaceutical Company catering to its clients across the globe. Established by Mr. Bhupinder Singh Manhas in 1983, our core competencies are in manufacturing and exporting of Active Pharmaceutical Ingredients mainly Metformin HCl, Fenofibrate, Divalproex Sodium, Riboflavin Phosphate Sodium, Glycopyrrolate/Glycopyrronium bromide and more.

Bachem offers a comprehensive array of services to the pharmaceutical and biotechnology sectors. It specializes in creating innovative and efficient manufacturing procedures, as well as the dependable production of peptide-based active pharmaceutical ingredients. The company is headquartered in Switzerland and has branch offices in Europe, the United States, and Asia, thus ensuring a worldwide presence with greater expertise.

Fisvi is a distinguished Italian company with a proud heritage in the manufacturing and innovation sectors. Specializing in advanced materials and cutting-edge solutions, Fisvi offers a wide range of products tailored to meet the demands of various industries, including construction, automotive, and industrial applications. Their product lineup includes high-quality insulation materials, adhesives, sealants, and other specialized components designed to enhance performance and durability.

Transo-Pharm, a fully authorized and accredited distributor, specializes in pharmaceutical components for the medical and veterinary sectors. It provides assistance to customers throughout the entire API life cycle, from product innovation to sales. Transo-Pharm acts as a sourcing and regulatory marketing representative for API producers. It assists customers in establishing DMFs and offers GMP advisory services. With a dedicated regulatory division, a storage facility, proprietary IPs for API procedures, and collaborations with research facilities, Transo-Pharm offers a broad array of services. It operates from its establishments in Shanghai, Hong Kong, Singapore, and the United States.

Our proprietary products (APIs) cater to the general pharmaceutical sector. We consistently deliver high-quality products and services, utilizing some of the most challenging chemical technologies in the world responsibly and continuously

Yangtze River Pharmaceutical Group, also known as YRPG, is a major pharmaceutical conglomerate based in China that was established in 1971. As of July 2019, YRPG spans over 3 million square meters and operates 14 manufacturing subsidiaries situated in various areas including Beijing, Shanghai, Nanjing, and Guangzhou. It has also established research and development as well as production facilities for innovative chemical medicine and traditional patented products.

Bal Pharma is a leading Indian Pharmaceutical Company with 32+years’ of experience, specialized in Prescription Drugs, Generic medicines & OTC Products, Intravenous Infusion and Bulk Actives. We strive hard to improve the quality of life for patients by providing them products that are Safe, Effective, High Quality and Affordable. Bal Pharma’s API and FDF are produced at world class manufacturing facilities. Our APIs are largely exported to Europe, Far East, Latin America, Africa, Middle East and other World markets. The FDF are exported to Semi-Regulated, Non-Regulated market and are now foraying to regulated market. We are also one of the strong contenders for World Tender Business.

Jiangsu Nhwa Pharmaceutical Co., Ltd. was initially founded in 1978. In year 2008, Nhwa listed on the Shenzhen stock exchange with the stock code 002262. NHWA Pharma integrates R&D, production and sales together, as national psychiatric drugs designated unit, national high-tech enterprise, China’s top 100 pharmaceutical enterprises, national intellectual property rights demonstration unit, national "20 years 20 star" medical quality management enterprise star unit, international environmental certification (ISO14000) confirmed enterprise, the first batch of innovative enterprises in Jiangsu province, and vice President unit of China narcotic drug association.

Dongkook Pharmaceuticals was established in 1968 and since its establishment, Dongkook has focused on research and development as well as technological innovation. Dongkook is renowned for its over-the-counter products with high brand values in South Korea. Moreover, Dongkook has created and manufactured exceptional therapeutic products such as anesthetics, contrast media, and anti-cancer agents. Dongkook has gained recognition from both domestic and international regulatory authorities for the quality of its final products, medical devices, and APIs

SI Group is a global leader in the innovative technology of performance additives, process solutions, and chemical intermediates. Our solutions are essential to many diverse industries and applications, creating extraordinary results. We drive value by enhancing the quality, performance, and durability of countless items we use every day. We are on a journey to captivate our customers at every level. Whether that means expanding our capabilities, global reach, or providing new innovations and technologies that create value. Our approach is customized to exceed customer needs and deliver superior performance.